The Neovent, designed by AIM Tech, is a low cost hydrostatic dual pressure ventilator for infants in respiratory distress.
SDG 3: Good Health and Well-Being
Market Suggested Retail Price
Target Users (Target Impact Group)
Community, Small and Medium-sized Enterprises
Distributors / Implementing Organizations
The product is in the clinical trial phase, so there is no distribution as of yet. They plan to do a market launch in 2019. Interview with representative
This product is a prototype. The designers constructed it in Dr. Peter Gustafson’s lab in WMU’s College of Engineering and Applied Sciences.
Intellectural Property Type
User Provision Model
The product is currently in clinical trials and not yet available for purchase. The projected market launch is planned for 2019. Interview with representative
Distributions to Date Status
20 machines are being tested in Nepal and an additional 2 are in trials in Kenya. Interview with representative
The Neovent is an infant ventilator which delivers dual level treatment. It does so by collecting bubbles, rising due to buoyancy, venting the bubbles and sinking. This cycle then repeats.
Technical support is provided by the manufacturer while the product undergoes clinical trials. Interview with representative
Replacement components are not yet available.
The Neovent can support 4 patients per device and run continuously for one month.
Manufacturer Specified Performance Parameters
Performance Targets include: - With training, local staff should be able to set up the Neovent in under 2 minutes, 30 seconds - 4 patients per device - 6 PI testing nodes
Vetted Performance Status
The product is currently in clinical trials in Kenya and Nepal.
Complementary Technical Systems
Academic Research and References
John S, John A, Steiner A. NeoVent: Global Low Cost, Low-Tech Respiratory Support for Infants. Michigan Journal of Medicine. 2018;3(1).
Compliance with regulations
The device is undergoing clinical trials.
The product is featured as 2018 National iShow winner.